Files and links (1)
Wong-AmJAddict-AAAP-Buprenorphine-2026-p220455.15 kB
Published, Version of Record (VoR) Access upon request
Conference poster
Buprenorphine Dosing in Patients with Kratom Use Disorder: A Descriptive Study of Associations with Age, Sex, and Kratom Use History
The American journal on addictions, v 35(2), pp 220-220
Mar 2026
Abstract
Introduction
Kratom, derived from Mitragyna speciosa, is growing in use in the U.S. but remains poorly understood. 12,17 Acting on opioid receptors, it causes stimulation, sedation, dependence, and withdrawal. 3 Its opioid-like effects are often missed on toxicology screens, contributing to under-diagnosis despite thousands of associated deaths in recent years. 7 Buprenorphine shows promise but remains under used and understudied for Kratom withdrawal. This review examines buprenorphine dosing literature to guide treatment of Kratom Use Disorder (KUD).
Metrics
20 Record Views
Details
- Title
- Buprenorphine Dosing in Patients with Kratom Use Disorder: A Descriptive Study of Associations with Age, Sex, and Kratom Use History
- Creators
- Jaffrey O Wong - Family Health Centers of San DiegoDavid S Bennett - Drexel University, PsychiatryKarim Ghobrial-Sedky - Sharp HealthCare FoundationPaulette Cazares - Family Health Centers of San DiegoJoe Sepulveda - Family Health Centers of San Diego
- Publication Details
- The American journal on addictions, v 35(2), pp 220-220
- Conference
- American Academy of Addiction Psychiatry 36th Annual Meeting and Scientific Symposium, 36th (San Francisco, California, United States, 06 Nov 2025–09 Nov 2025)
- Publisher
- Wiley
- Number of pages
- 1
- Resource Type
- Conference poster
- Language
- English
- Academic Unit
- Psychiatry
- Web of Science ID
- WOS:001709602500098
- Other Identifier
- 991022170453304721